Moderna COVID-19 vaccine

RNA COVID-19 vaccine

Moderna COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

The Moderna COVID‑19 vaccine, codenamed mRNA-1273 and sold under the brand name Spikevax, is a COVID-19 vaccine developed by Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). It is used in people aged 18 years and older to provide protection against infection by the SARS-CoV-2 virus, which causes COVID-19. It is designed to be administered as two 0.5 mL doses given by intramuscular injection at an interval of 29 days apart.

1 shares	Share Tweet Save Post Send



Twitter suspends U.S. Republican Greene for posts Twitter Inc on Monday said it temporarily suspended Republican U.S. Representative Marjorie Taylor Greene's account for tweets which violated the social media's misinformation policy on COVID-19. Bryan.. Credit: Reuters - Politics Duration: 01:02Published 5 days ago

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens \| Oneindia News Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine ZyCov-D. An approval for Zydus' vaccine, would make it.. Credit: Oneindia Duration: 02:09Published 3 weeks ago

India gets 4th vaccine approved; Cipla to manufacture Moderna jabs for emergency use \| Oneindia News Today, Mumbai-based pharmaceutical company Cipla got a nod from the Drug Controller General of India to import Moderna's Covid-19 vaccine for emergency use as per the provisions of the New Drugs and.. Credit: Oneindia Duration: 01:22Published on June 29, 2021

Pfizer and Moderna jabs linked to Myocarditis cases Pfizer and Moderna jabs linked to Myocarditis cases Credit: Wochit News Duration: 01:05Published on June 26, 2021

CDC Says Cases of Heart Inflammation After 2nd COVID Shot Higher Than Expected, but Rare On Thursday, the Centers for Disease Control and Prevention said that there have been a higher-than-expected number of cases of heart inflammation in 16- to 24-year-olds after receiving their second.. Credit: Cover Video STUDIO Duration: 01:21Published on June 14, 2021

Moderna Applies for Full COVID-19 Vaccine Authorization On June 1, Moderna followed Pfizer in becoming the second pharmaceutical company to apply to the FDA for full vaccine approval for adults 18 and older Credit: Cover Video STUDIO Duration: 01:07Published on June 3, 2021

Pfizer and Moderna vaccines may arrive in India soon\| DCGI paves the way \| Oneindia News In a move to pave the way for the availability of vaccines like Pfizer and Moderna in India, the Drugs Controller General of India (DCGI) has exempted foreign Covid-19 vaccines approved by specific.. Credit: Oneindia Duration: 02:05Published on June 2, 2021

Moderna files for full U.S. approval of COVID-19 vaccine Moderna on Tuesday filed for full U.S. approval of its COVID-19 vaccine, becoming the second drugmaker to do so after Pfizer and its German partner BioNTech sought full clearance for their vaccine last.. Credit: Reuters - Politics Duration: 01:04Published on June 1, 2021

You Might Like

Moderna and Pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks' The Pfizer/BioNTech and Moderna jabs have been linked to cases of mild heart inflammation - but the benefits still outweigh the risks, according to European and UK health agencies. Sky News - Published 2 weeks ago
India expects 3-4 million Pfizer, Moderna vaccine doses through Covax by August- sources India expects to receive 3 million to 4 million doses of the Pfizer and Moderna Covid-19 shots through the Covax facility by August, two sources said, as it tries to expand inoculations to prevent.. IndiaTimes - Published 3 weeks ago
Indemnity issue holds up J&J, Pfizer and Moderna jabs IndiaTimes - Published 3 weeks ago

DCGI gives emergency use nod to Moderna’s vaccine Indian pharma major Cipla will “facilitate” the import of Covid vaccines donated by US biotech major Moderna, possibly in the near future, under licence for restricted use by India’s drug.. IndiaTimes - Published on June 29, 2021
Covid-19: Govt's five-fold strategy of management; Moderna gets nod as 4th vaccine in India, and more IndiaTimes - Published on June 29, 2021
India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the.. IndiaTimes - Published on June 29, 2021

Moderna seeks regulatory approval for its Covid-19 vaccine in India IndiaTimes - Published on June 29, 2021
Good news! Pfizer gears up to supply 1 billion vaccine doses to India in 2021, approval in "final stages" The Indian government may be set to grant indemnity from liability to Pfizer and Moderna in a bid to fast-track their vaccine's approval. DNA - Published on June 23, 2021
Moderna offers to sell booster shots from January; indemnity-waiver talks on US vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity.. IndiaTimes - Published on June 10, 2021
India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan Shringla Last month saw India getting the first batches of Suptink V vaccines, which will be also produced by Indian companies. DNA - Published on June 3, 2021

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their Covid-19 jabs in India, the Serum Institute of India (SII) has also sought protection.. IndiaTimes - Published on June 3, 2021
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer In a letter, DCGI Chief VG Somani letter said that this will be applicable for vaccines that have already been approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or listed for.. IndiaTimes - Published on June 2, 2021
COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trials Cipla, which has been looking to commit USD 1 billion into bringing Moderna's single-dose mRNA booster vaccine to India, also requested an exemption. DNA - Published on June 2, 2021	Government in talks to boost vaccine arsenal The government is in talks with global vaccine giants Moderna and Pfizer to source Covid-19 shots on an immediate basis, to increase supply in the next two-three months itself. While the Centre expects.. IndiaTimes - Published on May 25, 2021
Moderna's single-dose Covid-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021 Moderna is expecting to launch a single-dose Covid-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in.. IndiaTimes - Published on May 25, 2021	Moderna refuses to send vaccine doses directly to Punjab government, here's why Divulging further, the State Nodal Officer said that reply was received from Moderna only in which the company refused to deal with State Government. DNA - Published on May 24, 2021Also reported by •IndiaTimes
Will deal only with Centre: Pfizer, Moderna Massachusetts-based biotechnology company Moderna, which has developed a messenger RNA (mRNA) vaccine to tackle Covid-19, has declined the Punjab government’s request for direct supply of its vaccine.. IndiaTimes - Published on May 23, 2021	Covid-19: Private hospital chains in talks to offer imported vaccines Private hospital chains across the country, including the Chennai-based Apollo group and Delhi-based Fortis Healthcare, and Mumbai-based Hinduja Hospital, are discussing modalities to offer.. IndiaTimes - Published on April 22, 2021
India paves way for foreign Covid-19 vaccines: Side effects, risks of Pfizer, Moderna, Sputnik, J&J IndiaTimes - Published on April 15, 2021	Covid-19 vaccine: Pfizer, J&J entry could still be months away US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While.. IndiaTimes - Published on April 13, 2021
India seeks imports of Covid vaccines as cases soar India is to fast-track emergency approvals for Covid-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna.. IndiaTimes - Published on April 13, 2021	Mix and match vaccine study extended to include Moderna and Novavax jabs A study assessing the benefits of mixing and matching coronavirus vaccines has been extended to include the Moderna and Novavax jabs. Sky News - Published on April 13, 2021
'More than enough' doses of Pfizer and Moderna for under-30s, says Hancock The UK has "more than enough" doses of Pfizer and Moderna jabs for under-30s, Health Secretary Matt Hancock has told Sky News. Sky News - Published on April 8, 2021	Everything you need to know about the Moderna vaccine The Moderna coronavirus vaccine is the third jab to be rolled out in the UK, alongside the Pfizer/BioNTech and Oxford University-AstraZeneca jabs. Sky News - Published on April 7, 2021
Dolly Parton Gets First Dose of Moderna COVID Vaccine, Busts out New Song Dolly Parton's employing her enormous talent and wealth to encourage folks to follow in her awesome footsteps, and get the COVID-19 vaccine. The beloved "9 to 5" singer got her first dose of the.. TMZ.com - Published on March 2, 2021

Moderna COVID-19 vaccine

RNA COVID-19 vaccine

Moderna COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

You Might Like

Moderna and Pfizer jabs linked to mild heart inflammation but 'benefits still outweigh risks'

India expects 3-4 million Pfizer, Moderna vaccine doses through Covax by August- sources

Indemnity issue holds up J&J, Pfizer and Moderna jabs

DCGI gives emergency use nod to Moderna’s vaccine

Covid-19: Govt's five-fold strategy of management; Moderna gets nod as 4th vaccine in India, and more

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

Moderna seeks regulatory approval for its Covid-19 vaccine in India

Good news! Pfizer gears up to supply 1 billion vaccine doses to India in 2021, approval in "final stages"

Moderna offers to sell booster shots from January; indemnity-waiver talks on

India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan Shringla

After Pfizer, Serum Institute seeks indemnity over Covid-19 vaccine: Sources

DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step closer

COVID-19: Big relief for foreign vaccine makers as DCGI exempts post-approval bridging trials

Government in talks to boost vaccine arsenal

Moderna's single-dose Covid-19 vaccine in India likely next year; Pfizer ready with 5 crore doses for 2021

Moderna refuses to send vaccine doses directly to Punjab government, here's why

Will deal only with Centre: Pfizer, Moderna

Covid-19: Private hospital chains in talks to offer imported vaccines

India paves way for foreign Covid-19 vaccines: Side effects, risks of Pfizer, Moderna, Sputnik, J&J

Covid-19 vaccine: Pfizer, J&J entry could still be months away

India ​seeks imports of Covid vaccines as cases soar

Mix and match vaccine study extended to include Moderna and Novavax jabs

'More than enough' doses of Pfizer and Moderna for under-30s, says Hancock

Everything you need to know about the Moderna vaccine

Dolly Parton Gets First Dose of Moderna COVID Vaccine, Busts out New Song

India seeks imports of Covid vaccines as cases soar